Literature DB >> 24760243

Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methods.

A Tsampalieros1, M K Berkenstock, B S Zemel, L Griffin, J Shults, J M Burnham, R N Baldassano, M B Leonard.   

Abstract

UNLABELLED: This study of changes in dual energy x-ray absorptiometry (DXA) spine BMD following diagnosis and treatment for childhood Crohn's disease demonstrated that changes in conventional posteroanterior BMD results were confounded by impaired growth, and suggested that lateral spine measurements and strategies to estimate volumetric BMD were more sensitive to disease and treatment effects.
INTRODUCTION: We previously reported significant increases in peripheral quantitative CT (pQCT) measures of trabecular volumetric bone mineral density (vBMD) following diagnosis and treatment of pediatric Crohn's disease (CD). The objective of this study was to compare pQCT trabecular vBMD and three DXA measures of spine BMD in this cohort: (1) conventional posteroanterior BMD (PA-BMD), (2) PA-BMD adjusted for height Z (PA-BMDHtZ), and (3) width-adjusted volumetric BMD (WA-BMD) estimated from PA and lateral scans.
METHODS: Spine DXA [lumbar (L1-4) for posteroanterior and L3 for lateral] and tibia pQCT scans were obtained in 65 CD subjects (ages 7-18 years) at diagnosis and 12 months later. BMD results were converted to sex, race, and age-specific Z-scores based on reference data in >650 children (ages 5-21 years). Multivariable linear regression models identified factors associated with BMD Z-scores.
RESULTS: At CD diagnosis, all BMD Z-scores were lower compared with the reference children (all p values <0.01). The pQCT vBMD Z-scores (-1.46 ± 1.30) were lower compared with DXA PA-BMD (-0.75 ± 0.98), PA-BMDHtZ (-0.53 ± 0.87), and WA-BMD (-0.61 ± 1.10) among CD participants. Only PA-BMD Z-scores were correlated with height Z-scores at baseline (R = 0.47, p < 0.0001). pQCT and WA-BMD Z-scores increased significantly over 12 months to -1.04 ± 1.26 and -0.20 ± 1.14, respectively. Changes in all four BMD Z-scores were positively associated with changes in height Z-scores (p < 0.05). Glucocorticoid doses were inversely associated with changes in WA-BMD (p < 0.01) only.
CONCLUSIONS: Conventional and height Z-score-adjusted PA DXA methods did not demonstrate the significant increases in trabecular vBMD noted on pQCT and WA-BMD scans. WA-BMD captured glucocorticoid effects, potentially due to isolation of the vertebral body on the lateral projection. Future studies are needed to identify the BMD measure that provides greatest fracture discrimination in CD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760243      PMCID: PMC4532327          DOI: 10.1007/s00198-014-2701-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  41 in total

1.  Osteoporosis: an unusual presentation of childhood Crohn's disease.

Authors:  M Thearle; M Horlick; J P Bilezikian; J Levy; J M Gertner; L S Levine; M Harbison; W Berdon; S E Oberfield
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

2.  Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6.

Authors:  Francisco A Sylvester; Nancy Wyzga; Jeffrey S Hyams; Gloria A Gronowicz
Journal:  J Bone Miner Res       Date:  2002-04       Impact factor: 6.741

3.  Racial disparity in fracture risk between white and nonwhite children in the United States.

Authors:  Tishya A L Wren; John A Shepherd; Heidi J Kalkwarf; Babette S Zemel; Joan M Lappe; Sharon Oberfield; Frederick J Dorey; Karen K Winer; Vicente Gilsanz
Journal:  J Pediatr       Date:  2012-09-10       Impact factor: 4.406

4.  Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.

Authors:  L Dalle Carbonare; M E Arlot; P M Chavassieux; J P Roux; N R Portero; P J Meunier
Journal:  J Bone Miner Res       Date:  2001-01       Impact factor: 6.741

5.  Inhibition of osteoblast differentiation by tumor necrosis factor-alpha.

Authors:  L Gilbert; X He; P Farmer; S Boden; M Kozlowski; J Rubin; M S Nanes
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

6.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version.

Authors:  Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

7.  The LMS method for constructing normalized growth standards.

Authors:  T J Cole
Journal:  Eur J Clin Nutr       Date:  1990-01       Impact factor: 4.016

8.  Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area.

Authors:  S F Ahmed; I A Horrocks; T Patterson; S Zaidi; S C Ling; P McGrogan; L T Weaver
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-03       Impact factor: 2.839

9.  Self-assessment of sexual maturity status in children with Crohn's disease.

Authors:  Joan I Schall; Edisio J Semeao; Virginia A Stallings; Babette S Zemel
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

10.  Lumbar spine bone mineral density at diagnosis and during follow-up in children with IBD.

Authors:  Arun Gupta; Shirley Paski; Robert Issenman; Colin Webber
Journal:  J Clin Densitom       Date:  2004       Impact factor: 2.963

View more
  6 in total

1.  Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures.

Authors:  Klara Maratova; Ondrej Hradsky; Jana Matyskova; Ivana Copova; Ondrej Soucek; Zdenek Sumnik; Jiri Bronsky
Journal:  Eur J Pediatr       Date:  2017-08-24       Impact factor: 3.183

2.  Increases in IGF-1 After Anti-TNF-α Therapy Are Associated With Bone and Muscle Accrual in Pediatric Crohn Disease.

Authors:  Mark D DeBoer; Arthur M Lee; Kirabo Herbert; Jin Long; Meena Thayu; Lindsay M Griffin; Robert N Baldassano; Lee A Denson; Babette S Zemel; Michelle R Denburg; Rita Herskovitz; Mary B Leonard
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

3.  Changes in pediatric DXA measures of musculoskeletal outcomes and correlation with quantitative CT following treatment of acute lymphoblastic leukemia.

Authors:  Sogol Mostoufi-Moab; Andrea Kelly; Jonathan A Mitchell; Joshua Baker; Babette S Zemel; Jill Brodsky; Jin Long; Mary B Leonard
Journal:  Bone       Date:  2018-04-19       Impact factor: 4.398

4.  Effect of Low-Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial.

Authors:  Mary B Leonard; Justine Shults; Jin Long; Robert N Baldassano; J Keenan Brown; Kevin Hommel; Babette S Zemel; Soroosh Mahboubi; Krista Howard Whitehead; Rita Herskovitz; Dale Lee; Joseph Rausch; Clinton T Rubin
Journal:  J Bone Miner Res       Date:  2016-03-31       Impact factor: 6.741

5.  Evaluation of bone mineral density and body compositions interrelation in young and middle-aged male patients with Crohn's disease by quantitative computed tomography.

Authors:  Xueli Zhang; Kun Peng; Gang Li; Lidi Wan; Tingting Xu; Zhijun Cui; Fuxia Xiao; Li Li; Zhanju Liu; Lin Zhang; Guangyu Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

Review 6.  Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review.

Authors:  Stefano Stagi; Loredana Cavalli; Tiziana Cavalli; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2016-09-26       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.